FOXO TECHNOLOGIES INC. Amortization of Intangible Assets
FOXO TECHNOLOGIES INC. (FOXO) reported Amortization of Intangible Assets of $21.68 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. amortization of intangible assets for the quarter ending 2026-06-30 was $21.68K, a 492.65% increase year-over-year.
- FOXO TECHNOLOGIES INC. amortization of intangible assets for the quarter ending 2026-03-31 was $22.40K, a 512.11% increase year-over-year.
- FOXO TECHNOLOGIES INC. amortization of intangible assets for the quarter ending 2025-12-31 was $21.02K, a 89.49% decline year-over-year.
- FOXO TECHNOLOGIES INC. amortization of intangible assets for the quarter ending 2025-09-30 was $3.66K, a 98.78% decline year-over-year.
- FOXO TECHNOLOGIES INC. amortization of intangible assets for fiscal 2025 was $31.99K, a 96.80% decline from fiscal 2024.
- FOXO TECHNOLOGIES INC. amortization of intangible assets for fiscal 2024 was $1.00M, a 23.08% decline from fiscal 2023.
- FOXO TECHNOLOGIES INC. amortization of intangible assets for fiscal 2023 was $1.30M, a 1.33% increase from fiscal 2022.
- FOXO TECHNOLOGIES INC. amortization of intangible assets for fiscal 2022 was $1.28M.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $21.68K 10-Q · filed 2026-08-14 | $44.08K 10-Q · filed 2026-08-14 | $65.09K derived: sum of 3 quarters · filed 2026-08-14 | $68.75K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $22.40K 10-Q · filed 2026-05-15 | $43.41K derived: sum of 2 quarters · filed 2026-05-15 | $47.07K derived: sum of 3 quarters · filed 2026-05-15 | $50.73K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $21.02K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $24.68K derived: sum of 2 quarters · filed 2026-04-15 | $28.33K derived: sum of 3 quarters · filed 2026-08-14 | $31.99K 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | $3.66K 10-Q · filed 2025-11-10 | $7.32K derived: sum of 2 quarters · filed 2026-08-14 | $10.97K 10-Q · filed 2025-11-10 | $210.97K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $3.66K 10-Q · filed 2026-08-14 | $7.32K 10-Q · filed 2026-08-14 | $207.32K derived: sum of 3 quarters · filed 2026-08-14 | $507.32K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $3.66K 10-Q · filed 2026-05-15 | $203.66K derived: sum of 2 quarters · filed 2026-05-15 | $503.66K derived: sum of 3 quarters · filed 2026-05-15 | $803.66K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $500.00K derived: sum of 2 quarters · filed 2026-04-15 | $800.00K derived: sum of 3 quarters · filed 2026-04-15 | $1.00M 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | $300.00K 10-Q · filed 2025-11-10 | $257.00K 10-Q · filed 2024-11-19 | $600.00K derived: sum of 2 quarters · filed 2025-11-10 | $800.00K 10-Q · filed 2025-11-10 | $773.00K 10-Q · filed 2024-11-19 | $929.67K derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | $300.00K 10-Q · filed 2025-08-19 | $258.00K 10-Q · filed 2024-08-19 | $500.00K 10-Q · filed 2025-08-19 | $515.00K 10-Q · filed 2024-08-19 | $629.67K derived: sum of 3 quarters · filed 2025-08-19 | $699.67K derived: sum of 4 quarters · filed 2025-08-19 | ||
| 2024-03-31 | $257.67K 10-Q/A · filed 2025-08-19 | $922.00K 10-Q · filed 2024-06-28 | $329.67K derived: sum of 2 quarters · filed 2025-08-19 | $399.67K derived: sum of 3 quarters · filed 2025-08-19 | $636.67K derived: sum of 4 quarters · filed 2025-08-19 | |||
| 2023-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $142.00K derived: sum of 2 quarters · filed 2025-04-15 | $379.00K derived: sum of 3 quarters · filed 2025-04-15 | $1.30M 10-K · filed 2025-04-15 | $1.26M 10-K · filed 2024-06-06 | |||
| 2023-09-30 | $70.00K 10-Q · filed 2024-11-19 | $49.00K 10-Q · filed 2024-01-19 | $307.00K derived: sum of 2 quarters · filed 2024-11-19 | $1.23M 10-Q · filed 2024-11-19 | $1.21M 10-Q · filed 2024-01-19 | |||
| 2023-06-30 | $237.00K 10-Q · filed 2024-08-19 | $1.16M 10-Q · filed 2024-08-19 | ||||||
| 2023-03-31 | $257.00K 10-Q · filed 2024-06-28 | |||||||
| 2022-12-31 | $1.28M 10-K · filed 2024-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |